Stoke Therapeutics, Inc. (STOK)
33.51
+0.32
(+0.96%)
USD |
NASDAQ |
Mar 20, 16:00
33.66
+0.15
(+0.45%)
After-Hours: 20:00
Stoke Therapeutics EPS Diluted (Quarterly) : -0.9922 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Krystal Biotech, Inc. | 1.699 |
| Scholar Rock Holding Corp. | -0.8824 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Zymeworks, Inc. | -0.547 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -57.93M |
| Revenue (Quarterly) | 1.402M |
| Total Expenses (Quarterly) | 59.34M |
| Enterprise Value | 1.701B |
| Gross Profit Margin (Quarterly) | 24.75% |
| Profit Margin (Quarterly) | -4.13K% |
| Earnings Yield | -0.44% |
| Normalized Earnings Yield | -0.4432 |